We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eli Lilly CEO David Ricks has expressed concern that the new variant of the coronavirus that causes COVID-19 first reported in South Africa might be resistant to the company’s antibody treatment bamlanivimab. Read More
Brazil’s Butantan Institute reported that Sinovac’s COVID-19 vaccine, CoronaVac, demonstrated an overall efficacy of only 50.38 percent in a phase 3 trial, putting it barely over the World Health Organization’s 50 percent efficacy threshold for approval. Read More
Operation Warp Speed (OWS)’s chief adviser Moncef Slaoui submitted his resignation Tuesday but said he will stay on in that role for 30 days after Jan. 21 to support the incoming administration. Read More
As Johnson & Johnson (J&J) nears the release of critical phase 3 trial results and potential emergency authorization for its promising COVID-19 vaccine, the company has reportedly hit speedbumps in manufacturing doses. Read More
The Irvine, Calif.-based company said it has already received orders for the test in Europe and is gearing up to ship them “in the coming weeks.” Read More
Bharat Biotech has signed an agreement with the Brazilian company Precisa Medicamentos to supply 12 million doses of its India-developed COVID-19 vaccine Covaxin to Brazil. Read More
HHS announced yesterday it will no longer stockpile millions of COVID-19 vaccine doses held to ensure Americans receive their second shot, but will distribute them immediately and give states two weeks to comply with new federal rules for dose allocation. Read More
AstraZeneca (AZ) has filed for EU approval of its COVID-19 vaccine and a conditional marketing authorization is expected in late January following a Jan. 29 meeting of the European Medicines Agency’s (EMA) expert panel on human medicines. Read More
The Malvern, Pa.-based diagnostics maker said that it intends to immediately begin supplying the U.S. market with the test kit on a national scale. Read More
Indonesia’s Food and Drug Authority has cleared Sinovac’s COVID-19 vaccine, CoronaVac, for emergency use, making it the first country outside of China to authorize the Chinese state-owned drugmaker’s shot. Read More
Moderna is following up on the success of its messenger RNA-based COVID-19 vaccine with plans to develop inoculations for numerous other infectious diseases, the company said Monday. Read More